Literature DB >> 535131

2'-Deoxycytidine hydrochloride protection of mice against the lethal toxicity of cytosine arabinoside. Absence of protection of bone marrow lymphocytes.

V M Buchman, N I Belyanchikova, D M Mkheidze, T A Litovchenko, M R Lichinitser, M F Barkhotkina, G J Svet-Moldavsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 535131     DOI： 10.1007/BF00254736

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  26 in total

1.  THE REVERSAL OF CYTOSINE ARABINOSIDE ACTIVITY IN VIVO BY DEOXYCYTIDINE.

Authors:  J S EVANS; G D MENGEL
Journal:  Biochem Pharmacol       Date:  1964-07       Impact factor: 5.858

2.  The effect of purines, nucleosides, and nucleotides on the carcinostatic action of 8-azaguanine.

Authors:  A GELLHORN; E HIRSCHBERG; A KELLS
Journal:  J Natl Cancer Inst       Date:  1954-02       Impact factor: 13.506

3.  The reversal of methotrexate toxicity by thymidine with maintenance of antitumour effects.

Authors:  M H Tattersall; B Brown; E Frei
Journal:  Nature       Date:  1975-01-17       Impact factor: 49.962

4.  Regional protection in cancer chemotherapy. II. Preliminary studies with hypogastric artery infusion of thymidine during treatment with 5-iodo-2'-deoxyuridine.

Authors:  J B MARK; P CALABRESI
Journal:  Cancer Chemother Rep       Date:  1962-02

5.  [Influence of Brucella abortus on the course of acute myeloid leukemia in mice].

Authors:  K L Chimishkian; N I Belianchikova; V N Kostrykina; E N Meĭland
Journal:  Vopr Virusol       Date:  1977 Mar-Apr

6.  Selective suppression of humoral and cellular immunity with cytosine arabinoside.

Authors:  D E Griswold; G H Heppner; P Calabresi
Journal:  Cancer Res       Date:  1972-02       Impact factor: 12.701

7.  [The principle of selective protection in chemotherapy of malignant tumors].

Authors:  G Ia Svet-Moldavskiĭ; A I Pavlotskiĭ; L I Ravkina
Journal:  Vestn Akad Med Nauk SSSR       Date:  1967

8.  Isolation and antileukemic activity, in mice, of 1-beta-D-arabinofuranosylcytosine 5'-phosphate present in synthetic 5'-cytidylic acid.

Authors:  A W Schrecker; J A Mead; M J Urshel
Journal:  Biochem Pharmacol       Date:  1966-10       Impact factor: 5.858

9.  Fate of amethopterin-resistant mutants in L1210 mouse leukemia populations.

Authors:  A Hoshino; A M Albrecht; D J Hutchison
Journal:  Cancer Res       Date:  1966-05       Impact factor: 12.701

10.  Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies.

Authors:  M R Dollinger; J H Burchenal; W Kreis; J J Fox
Journal:  Biochem Pharmacol       Date:  1967-04       Impact factor: 5.858
View more
  2 in total

1.  Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis.

Authors:  K Bhalla; S Grant
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: interactions with deoxycytidine.

Authors:  A L Harris; D G Grahame-Smith
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.